Bronchogen
Status
No approved product. No FDA-approved labeling exists. Not an FDA-approved medicine. Status in Russia and other countries was not verified for this entry.
What it is
A bronchial-tissue bioregulator from the same Russian peptide family.
What published research measured
A synthetic short peptide from the Khavinson programme directed at bronchial and pulmonary tissue, proposed to support respiratory epithelium and studied by the originating group in chronic obstructive pulmonary disease contexts. Published work is preclinical and small-scale observational, single-institute and largely Russian-language, and the sources cited in this entry show no ClinicalTrials.gov registration and no independent replication. They do not establish benefit in any respiratory condition in a controlled trial, and this entry does not cite human pharmacokinetic data.
Source
Khavinson programme preclinical publications
Sources
No linked primary source is on file for this entry yet.
Educational use only, never medical advice. No doses.